Clinical Trial

taVNS for Breast Cancer Pain and Symptom Management

Recruiting
View on ClinicalTrials.gov →
Summary
1. To evaluate the feasibility and acceptability of a home-based taVNS intervention and follow-up for pain and symptom management in breast cancer survivors. 2. To investigate the impact of taVNS on secondary outcomes, including pain, anxiety, depression, fatigue, and the brain-gut axis (BGA) in breast cancer survivors.
Trial Details
NCT Number NCT07500012
Lead Sponsor Florida State University
Conditions Breast Cancer Survivors
Enrollment 40 participants
Start Date 2026-02-24
Primary Completion 2027-12 (estimated)
Study Completion 2028-02 (estimated)
Updated on ClinicalTrials.gov 2026-03-30